Evidence by cancer type
Metronomic therapy in head and neck cancer
126 studies and 25 trials indexed. 10 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingPhase 2United StatesNCT06997068Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationMayo Clinic
- RecruitingPhase 3ChinaNCT07590024RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal CarcinomaCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingNot statedChinaNCT07618078Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPCCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 2SingaporeNCT06093061Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaNational Cancer Centre, Singapore
- RecruitingPhase 3ChinaNCT06239727Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment ResponseSun Yat-sen University
- RecruitingPhase 3ChinaNCT07154069Adaptive Immunotherapy for Nasopharyngeal CarcinomaSun Yat-sen University
- RecruitingPhase 2ChinaNCT06494995AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic TherapyFudan University
- RecruitingNot statedSingaporeNCT05517135tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)National Cancer Centre, Singapore
- RecruitingPhase 3ChinaNCT05342792Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal CarcinomaSun Yat-sen University
- Not yet recruitingPhase 2EgyptNCT07361133Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNational Cancer Institute, Egypt
See all 25 trials for head and neck cancer in the trial finder
Newest studies
- StudyJ Clin Oncol2026 Nov 10Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update.Chen YP, et al.
- StudyOral Dis2026 Nov 5Metronomic Tegafur-Uracil Maintenance Therapy in Oral Squamous Cell Carcinoma Following Adjuvant Chemoradiotherapy.Lu HJ, et al.
- StudyOral Dis2026 Nov 4An Update of Management Strategies in Locally Advanced Oral Cancer.Singh A and Chaturvedi P
- ReviewHNO2026 Oct 15[Nonimmunological systemic therapies in head and neck cancer : Cytotoxic, targeted, EGFR-directed, and supportive approaches at ASCO 2026].Blaurock M, et al.
- ReviewOral Dis2026 Aug 18Tegafur-Uracil (UFUR) as Maintenance Therapy in Resectable and Unresectable Head and Neck Squamous Cell Carcinoma: A Narrative Review.Wang HC and Chu PY
- StudyJ Oncol Pharm Pract2026 Aug 14Assessment of drug utilization patterns and associated survival outcomes in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Insights from a resource-constrained set-up.Patel V, et al.
- ReviewCancers (Basel)2026 Aug 3Predictive Biomarkers of Metronomic Chemotherapy Response in Solid Tumors: Chasing an Elusive Signal.Wysocki PJ, et al.
- Phase 3 trialNat Cancer2026 JulLong-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.Tao YL, et al.
- StudyCancer Med2026 JunOptimizing Outcomes in Elderly HNSCC: Efficacy of UFT Metronomic Therapy.Lee HL, et al.
- Phase 3 trialJCO Glob Oncol2026 JunIntegrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).Kapoor A, et al.
- StudyJ Egypt Natl Canc Inst2026 Jun 1A real-world study of the effectiveness and safety of low-dose immunotherapy in addition to oral metronomic chemotherapy in recurrent and metastatic head and neck squamous cell carcinoma.Kothari R, et al.
- StudyIndian J Surg Oncol2026 AprEfficacy of Metronomic Oral Capecitabine, Methotrexate and Cyclophosphamide in Locally Advanced Operable Oral Cavity Squamous Cell Carcinoma - A Phase II Study.Chanda S, et al.
- StudyLancet Reg Health Southeast Asia2026 AprLow-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial.Marimuthu PK, et al.
- Clinical trialHead Neck2026 MarA Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients.Khadela A, et al.
- ReviewOtolaryngol Clin North Am2026 FebEvolving Neoadjuvant, Adjuvant, and Concurrent Systemic Therapy Strategies in Head and Neck Squamous Carcinoma.Menon N
- StudyJ Dent Sci2026 JanAdjuvant metronomic tegafur-uracil is associated with poorer outcomes and unfavorable histopathologic progression in oral squamous cell carcinomas.Hung KF, et al.
- StudyRecent Pat Anticancer Drug Discov2026Oral Metronomic Chemotherapy in Nasopharyngeal Carcinoma with Radiotherapy Interruptions: A Lesson Learned from the Lockdown Due to COVID-19.Zhou Y, et al.
- Clinical trialESMO Open2025 NovMOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.Borcoman E, et al.
- Meta-analysisHead Neck2025 NovEfficacy and Safety of Adjuvant Capecitabine in Locoregionally Advanced Nasopharyngeal Carcinoma: A Meta-Analysis of Phase III Randomized Trials With Subgroup Analysis by Neoadjuvant Chemotherapy.Ben Kridis W and Khanfir A
- StudyCureus2025 OctA Comparative Assessment of the Efficacy and Toxicity Profiles of Dual and Triple Oral Metronomic Chemotherapy in Advanced Head and Neck Cancers in a Tertiary Care Center.Nair RP, et al.
- StudyInfect Agent Cancer2025 Sep 24Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy.Guo LF, et al.
- StudyFront Oncol2025Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China.Cao Y, et al.
- Systematic reviewFront Oral Health2025Efficacy of oral metronomic chemotherapy in the management of head and neck squamous cell carcinoma-a systematic review.Segin Chandran AB, et al.
- Phase 3 trialCancer Lett2025 Jul 1Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes.Kothari R, et al.
- StudyOral Oncol2025 JunEvaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy.Shaikh N, et al.
- Phase 3 trialJCO Glob Oncol2025 MayTriple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study).Kapoor A, et al.
- Clinical trialESMO Open2025 AprMultimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial.Merlano MC, et al.
- StudyGulf J Oncolog2025 JanProspective observational study to assess the role of targeted agent Gefitinib as palliative treatment in residual, recurrent, and metastatic squamous cell carcinoma of head and neck.Prajapati R, et al.
- CommentaryCancer Res Treat2025 JanCommentary on "Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma".Topkan E, et al.
- CommentaryCancer Res Treat2025 JanReply to Commentary on "Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma".Wu SG
- ReviewCancer Lett2024 Dec 28Precision meets repurposing: Innovative approaches in human papillomavirus and Epstein-Barr virus-driven cancer therapy.Fernandes Q
- Meta-analysisJ Gastrointest Cancer2024 DecEfficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Gupta N, et al.
- StudyOral Oncol2024 NovGemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study.Yang R, et al.
- StudyCancer Res Treat2024 OctMetronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.Yu YF, et al.
- CommentaryOral Oncol2024 SepLetter to the editor, "Letter to the editor, "Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.".Shanmugam G
- StudyOral Oncol2024 SepShort-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.Dong S, et al.
- StudyJ Immunother Precis Oncol2024 AugNovel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy.Limaye S, et al.
- ReviewJ Maxillofac Oral Surg2024 AugOral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour.Kumar NAN, et al.
- ReviewCell Rep Med2024 Jun 18Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma.Jiang W, et al.
- StudyIndian J Surg Oncol2024 JunCombined Metronomic Chemo-immunotherapy (CMCI) in Head and Neck Cancers-An Experience from a Developing Country.Madabhavi I, et al.
